Hematology and Medical Oncology

As part of Emory University School of Medicine and Winship Cancer Institute, the faculty in the Department of Hematology and Medical Oncology are leaders in cancer research activity, providing the latest therapies for patient care, and training the next generation of hematologists and medical oncologists.

Welcome to Hematology and Medical Oncology

The Department of Hematology and Medical Oncology is focused on clinical and basic research, education, and delivering outstanding hematology and oncology clinical services to patients.

Message from the Chair

Dr. Sagar Lonial with patient in clinic room

Divisions

Research Areas

Our faculty consist of clinical and basic science investigators who conduct a broad range of basic, translational and clinical research on a variety of human malignancies. Through novel discoveries, we are leading the way to a better understanding and improved detection and treatment of cancer.

Fellowship Program

The Hematology and Medical Oncology Fellowship Program offered by Emory University School of Medicine and Winship Cancer Institute of Emory University provides clinical and research training in hematology and medical oncology.

Medical oncology fellows walking down hall on inpatient floor.

Winship Cancer Institute of Emory University

Winship Cancer Institute of Emory University is Georgia's only National Cancer Institute-designated comprehensive cancer center and serves as the coordinating center for cancer research, education and care throughout Emory University.

Upcoming Symposium

The Winship Melanoma and Cutaneous Oncology Symposium serves as a valuable forum for the presentation and discussion of newly available data. Participants will be provided with an update on practice-changing data in a practical and interactive format, fostering discussion and impacting clinical outcomes for patients with melanoma and other cutaneous malignancies.

The symposium will be held on March 2, 2024 at the Emory Conference Center Hotel. Registration to open in fall 2023.

News

Winship News

Emory leader presents new research showing remarkable promise for lung cancer treatment Jun. 3, 2024

Findings from the LAURA Phase III trial—presented at the ASCO Annual Meeting by Winship Executive Director Suresh Ramalingam, MD, and simultaneously published in The New England Journal of Medicine—show osimertinib significantly extends the time patients live without their cancer worsening, offering the first effective therapy and new hope for those with advanced EGFR-mutated non-small cell lung cancer.

Emory neurosurgeon Edjah K. Nduom appointed to National Cancer Advisory Board May. 17, 2024

President Biden has appointed Edjah K. Nduom, MD, to the National Cancer Advisory Board.

Charting the future: Q&A with Emory’s chief data and AI officer May. 10, 2024

Discover how Emory is advancing health care and academic excellence through the responsible use of AI.

Events

Main Calendar

Loading Events...